Filing Details

Accession Number:
0000899243-20-027697
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-06 21:28:03
Reporting Period:
2020-10-06
Accepted Time:
2020-10-06 21:28:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1662579 C4 Therapeutics Inc. CCCC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1132945 A Marc Cohen C/o C4 Therapeutics, Inc.
490 Arsenal Way, Suite 200
Watertown MA 02472
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-06 237,149 $0.00 370,024 No 4 C Indirect See Footnote
Common Stock Acquisiton 2020-10-06 1,482,183 $0.00 1,852,207 No 4 C Indirect See Footnote
Common Stock Acquisiton 2020-10-06 2,484,425 $0.00 2,484,425 No 4 C Indirect By Cobro Ventures Opportunity Fund, L.P.
Common Stock Acquisiton 2020-10-06 5,030 $19.00 5,030 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect By Cobro Ventures Opportunity Fund, L.P.
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series Seed Preferred Stock Disposition 2020-10-06 2,000,000 $0.00 237,149 $0.00
Common Stock Series A Preferred Stock Disposition 2020-10-06 12,500,000 $0.00 1,482,183 $0.00
Common Stock Series B Preferred Stock Disposition 2020-10-06 20,952,403 $0.00 2,484,425 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series Seed Preferred Stock, Series A Preferred Stock, and Series B Preferred Stock automatically converted into the Issuer's Common Stock on a 8.4335-to-one basis upon the closing of the Issuer's initial public offering on October 6, 2020 and had no expiration date.
  2. Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  3. Shares held by Cobro Ventures Opportunity Fund, L.P. ("Cobro Ventures"). The Reporting Person serves as a manager of Cobro Opportunity Fund GP, LLC, the general partner of Cobro Ventures, and may be deemed to exercise voting and investment power over the shares held by Cobro Ventures. The Reporting Person disclaims beneficial ownership of the shares held by Cobro Ventures except to the extent of his pecuniary interest therein.